2026 International Congress Archives - Page 107 of 208

Interaction Between Physical and Cognitive Function That Determines ADL Improvement in Hospitalized Patients with Parkinson’s Disease: Implications for Individualized Rehabilitation Strategies

R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto, Y. Yamano (Kawasaki City, Kanagawa Prefecture, Japan)
Interest in Clinical Trial Participation in Parkinson’s Disease: Insights from a Nationwide Registry

M. Peball, B. Heim, A. Djamshidian, F. Krismer, R. Katzenschlager, P. Schwingenschuh, W. Pirker, W. Poewe, K. Seppi (Innsbruck, Austria)
Interleaving Deep Brain Stimulation: Achieving Optimal Clinical Outcomes at Lower Per-contact Voltages and Energy Consumption

CY. Por, TT. Lim, O. Phokaewvarangkul, R. Bhidayasiri (Kuching, Malaysia)
Interleukin 6 in the assessment of Parkinson’s disease and Progressive Supranuclear Palsy

N. Madetko-Alster, M. Markiewicz, P. Chunowski, P. Alster (Warsaw, Poland)
International validation of the Neuropsychiatric Fluctuations Scale in patients with Parkinson’s disease

I. Debove, C. Rodriguez-Blazquez, A. Zenger, A. Ayala, M. Bereau, S. Bostantjopoulou, KR. Chaudhuri, MA. Qamar, E. Cubo, B. Falkenburger, C. Falup-Pecurariu, MJ. Forjaz, MM. Kurtis, H. Reichmann, P. Krack, P. Martinez-Martin (Bern, Switzerland)
International, multicenter validation study of the Shame in Parkinson’s disease (SPARK) Scale

C. Rodriguez-Blazquez, I. Debove, A. Ayala, V. Fleury, A. Zenger, M. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, MA. Qamar, H. Reichmann, S. Bostantjopoulou, M. Bereau, MJ. Forjaz, P. Martinez-Martin, P. Krack (Madrid, Spain)
Interplay of sex and GBA1 and LRRK2 genotype in Parkinson disease progression

J. Park, M. Yang, N. Masood, R. Ortega, D. Raymond, A. Wise, B. Green, K. Leaver, V. Katsnelson, V. Shanker, M. Swan, M. Pullman, A. Domingo, L. Ozelius, S. Bressman, C. Wang, R. Saunders-Pullman (New York, USA)
Interpretable AI for Quantitative Video-Based UPDRS Assessment of Hand Movements in Parkinson’s Disease

A. Irani, A. Mehrani, A. Soltani Mohammadi, K. Park, M. Mirian, R. Hosseini, H. Moradi, M. Mckeown (Vancouver, Canada)
Intersectin-1 (ITSN1) Loss-of-Function Variants in Parkinson’s Disease: Clinical Phenotypes and Neuropathological Insights

J. Frost, O. Serrano Asensio, J. Ooi, YK. Chia, S. Lim, Y. Tay, C. Lin, A. Robinson, C. Kobylecki, A. Tan, K. Kurian, C. Smith, D. Grosset, L. Parkkinen, Z. Jaunmuktane, T. Warner, C. Blauwendraat, R. Real, H. Morris, GP2. Consortium (London, United Kingdom)
Interventions in Friedreich’s Ataxia and their Influence on Patient-centric Outcomes: A Systematic Review

D. Sarwinska, M. Buchholz, A. Iskandar, M. Grobe-Einsler, T. Klockgether, J. Faber, B. Michalowsky (Greifswald, Germany)